Nasr Fascial Closure: A Novel Device for Fascial Closure in Laparoscopic Surgery

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06036303

Enrollment

160

Registered

2023-09-13

Start date

2023-09-15

Completion date

2023-12-15

Last updated

2023-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholecystolithiasis

Keywords

Laparoscopic removal

Brief summary

The study will investigate the efficacy and safety of a new fascial closure device Nasr Fascial Closure Device compared to the Karl Storz Berci Fascial Closure Device 26173AM.

Interventions

DEVICENasr fascial closure device

Nasr fascial closure device is a novel device for fascial closure

DEVICEBerci Fascial Closure Device

Berci Fascial Closure Device is a known device for fascial closure

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* age \> 18 * eligible for Laparoscopic cholecystectomy

Exclusion criteria

* refused to participate

Design outcomes

Primary

Measure	Time frame	Description
duration of port site closure	1 day	Duration in seconds
Rate of failure of port site	1 day	Rate of failure to close the port site

Secondary

Measure	Time frame	Description
Incidence of port site infection	1 month	Incidence of infection of the port site
Incidence of port site hernia	6 weeks	Incidence of hernia at the port site

Countries

Egypt

Contacts

Primary ContactMohie El-Din M Madany, MD

Mohie.madany@med.aswu.edu.eg01141341342

Backup ContactEmad R Issak, MSc

emangate@gmail.com01066208065

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026